Cardiology
Conference Coverage
ISCHEMIA trial hailed as practice changing
PHILADELPHIA – The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.
Conference Coverage
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
PHILADELPHIA –
Conference Coverage
Weaknesses exposed in valsartan recall
PHILADELPHIA – A population study in Canada exposed incomplete adherence after the valsartan recall of July 2018.
News from the FDA/CDC
FDA panel supports Vascepa expanded indication for CVD reduction
Icosapent ethyl (Vascepa), purified eicosapentaenoic acid, got unanimous support from an FDA panel for a new indication of reducing CVD events.
News from the FDA/CDC
FDA still concerned about biotin affecting troponin tests
The agency has issued an update to its 2017 safety communication.
Latest News
Statins cut long-term CVD risk in kids with familial hypercholesterolemia
There were no cardiovascular-related deaths and one event in treated patients who were followed for 20 years.
Conference Coverage
Low LDL-C and blood pressure can reduce lifetime CVD risk by 80%
PARIS – The effects were seen in those with genetic variants linked with low LDL cholesterol and systolic blood pressure.
Conference Coverage
CVD risk in black SLE patients 18 times higher than in whites
ATLANTA – “This study [identifies] a population that needs more attention, more targeted CVD prevention,” presenter Dr. Shivani Garg said.
Conference Coverage
Getting high heightens stroke, arrhythmia risks
Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies.
News
U.S. deaths from preventable causes occur more often in rural areas
In 2017, 21.7% of cancer deaths in the most rural counties were potentially preventable, compared with 3.2% in the most urban counties.
PURLs
Best timing for measuring orthostatic vital signs?
We typically take a blood pressure within 3 minutes of a patient rising from a supine to a standing position. But is that too long?